We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
-2.7%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$228M
AUM Growth
-$18.3M
Cap. Flow
-$9.44M
Cap. Flow %
-4.13%
Top 10 Hldgs %
58.67%
Holding
92
New
19
Increased
15
Reduced
21
Closed
24

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$2.65M
2
PYPL icon
PayPal
PYPL
+$1.2M
3
TSM icon
TSMC
TSM
+$1.05M
4
IBB icon
iShares Biotechnology ETF
IBB
+$912K
5
GLD icon
SPDR Gold Trust
GLD
+$877K

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$6.26M
2
AMGN icon
Amgen
AMGN
+$2.87M
3
VZ icon
Verizon
VZ
+$2.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$2.03M
5
INCY icon
Incyte
INCY
+$1.78M

Sector Composition

Rank Sector Weight
1 Healthcare 34.68%
2 Technology 11.59%
3 Communication Services 7.6%
4 Financials 4.91%
5 Consumer Discretionary 2.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
26
Pfizer
PFE
$143B
$2.41M 1.05%
46,500
-18,500
-28% -$960K
META icon
27
Meta Platforms (Facebook)
META
$1.42T
$2.36M 1.03%
+10,600
New +$2.65M
IMPL
28
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$2.34M 1.02%
367,058
+111,031
+43% +$839K
T icon
29
AT&T
T
$159B
$2.3M 1.01%
129,090
+6,620
+5% +$122K
AAPL icon
30
Apple
AAPL
$4.54T
$2.18M 0.96%
12,500
– –
SGEN
31
DELISTED
Seagen Inc. Common Stock
SGEN
$2.16M 0.95%
15,000
+1,500
+11% +$203K
LNSR icon
32
LENSAR
LNSR
$61.5M
$2.12M 0.93%
287,023
+7,235
+3% +$45.3K
REGN icon
33
PUT
Regeneron Pharmaceuticals
REGN
$78.5B
$2.1M 0.92%
+3,000
New +$1.9M
F icon
34
Ford
F
$58.5B
$2.08M 0.91%
123,000
-45,750
-27% -$870K
ALT icon
35
Altimmune
ALT
$552M
$1.92M 0.84%
316,000
+35,300
+13% +$260K
AERI
36
DELISTED
Aerie Pharmaceuticals
AERI
$1.73M 0.76%
189,565
-2,500
-1% -$19.3K
ET icon
37
Energy Transfer Partners
ET
$70.1B
$1.58M 0.69%
141,000
+47,000
+50% +$466K
MRVL icon
38
Marvell Technology
MRVL
$168B
$1.25M 0.55%
17,500
– –
QCOM icon
39
Qualcomm
QCOM
$155B
$1.15M 0.5%
7,500
– –
ITW icon
40
Illinois Tool Works
ITW
$82.6B
$1.06M 0.47%
5,075
+1,575
+45% +$353K
PYPL icon
41
PayPal
PYPL
$48.9B
$1.04M 0.46%
+9,000
New +$1.2M
SLV icon
42
iShares Silver Trust
SLV
$28B
$1.03M 0.45%
45,000
-22,500
-33% -$500K
STEW
43
SRH Total Return Fund
STEW
$1.79B
$964K 0.42%
65,000
-18,000
-22% -$257K
TSM icon
44
TSMC
TSM
$2.1T
$938K 0.41%
+9,000
New +$1.05M
IBB icon
45
iShares Biotechnology ETF
IBB
$9.34B
$912K 0.4%
+7,000
New +$912K
NOK icon
46
Nokia
NOK
$51B
$819K 0.36%
150,000
– –
XLP icon
47
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
$683K 0.3%
+9,000
New +$678K
GLD icon
48
CALL
SPDR Gold Trust
GLD
$131B
$632K 0.28%
+3,500
New +$614K
CSCO icon
49
Cisco
CSCO
$457B
$558K 0.24%
+10,000
New +$566K
DIS icon
50
Walt Disney
DIS
$167B
$549K 0.24%
+4,000
New +$578K
1
2
3 4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, DCF Advisers held 92 positions worth $228M, down 7.4% from $247M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

DCF Advisers withdrew a net $9.44M in Q1 2022, closing 24 positions and reducing 21 holdings. Its most notable exit was Amgen, an estimated $2.87M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in Meta Platforms (Facebook) worth $2.36M.

  • DCF Advisers's largest Q1 2022 buy was Meta Platforms (Facebook): 10,600 shares worth $2.36M.
  • DCF Advisers added most to SPDR Gold Trust in Q1 2022, an estimated $877K increase.
  • DCF Advisers's biggest Q1 2022 reduction was Intra-Cellular Therapies Inc., cutting an estimated $6.26M.
  • DCF Advisers fully exited Amgen in Q1 2022, selling an estimated $2.87M.
  • DCF Advisers's ten largest holdings make up 59% of its $228M portfolio in Q1 2022.
  • DCF Advisers opened 19 new positions and closed 24 in Q1 2022.
  • DCF Advisers's portfolio value fell 7.4% quarter-over-quarter to $228M.

Based on DCF Advisers's 13F filing for Q1 2022, filed 13 May 2022.